Loading provider…
Loading provider…
Gynecologic Oncology Physician in Los Angeles, CA
NPI: 1396888947Primary Practice Location
UCLA Gynecologic Oncology Assoc
104 S Medio Dr, Los Angeles, CA
Primary Employer
UCLA Gynecologic Oncology Assoc
mednet.ucla.edu
HQ Phone
Get M.D. Dana's Phone Numberphone_androidMobile
Get M.D. Dana's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2005 - 2027
AZ State Medical License
2011 - 2026
AZ State Medical License
CA State Medical License

American Board of Obstetrics and Gynecology
Obstetrics & Gynecology

American Board of Obstetrics and Gynecology
Gynecologic Oncology
University of California (Irvine)
Fellowship • Gynecologic Oncology
2007 - 2011
Residency • Obstetrics and Gynecology
2003 - 2007
UC Irvine School of Medicine
medschool.uci.edu
Medical School
Until 2003
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 25 | 40 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 23 | 23 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 15 | 16 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 14 | 14 |
Authors: Tatiana Chou
Journal: Obstet Gynecol
Lead Sponsor: Gynecologic Oncology Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, BEHAVIORAL: Exercise Intervention, BEHAVIORAL: Compliance Monitoring, OTHER: Educational Intervention, BEHAVIORAL: Behavioral Dietary Intervention, OTHER: Counseling
Lead Sponsor: Yale University
Collaborators: Genentech, Inc.
Intervention / Treatment: DRUG: Trastuzumab, DRUG: Carboplatin/Paclitaxel